IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 1113 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Efficacy of low dose intravenous immunoglobulins in children with toxic epidermal necrolysis: An open uncontrolled study

Mangla Kanu, Rastogi Swati, Goyal Puneet, Solanki Rekha B, Rawal Ranjan C

Year : 2005| Volume: 71| Issue : 6 | Page no: 398-400

   This article has been cited by
 
1 Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens–Johnson syndrome, toxic epidermal necrolysis and DRESS)
M.T. Belver,A. Michavila,I. Bobolea,M. Feito,T. Bellón,S. Quirce
Allergologia et Immunopathologia. 2016; 44(1): 83
[Pubmed]  [Google Scholar] [DOI]
2 Toxic epidermal necrolysis treatment and outcomes: a retrospective analysis of 10 patients treated with intravenous immunoglobulin
Darius Mehregan,Anthony Van Vreede,Mark Goralewski
International Journal of Dermatology. 2015; : n/a
[Pubmed]  [Google Scholar] [DOI]
3 An atypical presentation of pulmonary air-leak syndrome and multisystem toxic epidermal necrolysis
Joseph T. Ellenburg,David Josey
Pediatric Pulmonology. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
4 Rapid onset of Stevens-Johnson syndrome and toxic epidermal necrolysis after ingestion of acetaminophen
Eun-Jin Kim,Hyun Lim,So Young Park,Sujeong Kim,Sun-Young Yoon,Yun-Jeong Bae,Hyouk-Soo Kwon,You Sook Cho,Hee-Bom Moon,Tae-Bum Kim
Asia Pacific Allergy. 2013; 4(1): 68
[Pubmed]  [Google Scholar] [DOI]
5 Toxic epidermal necrolysis
Robert A. Schwartz,Patrick H. McDonough,Brian W. Lee
Journal of the American Academy of Dermatology. 2013; 69(2): 187.e1
[Pubmed]  [Google Scholar] [DOI]
6 Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012
Sheena N. Ramasamy,Cameron S. Korb-Wells,Diluk R. W. Kannangara,Myles W. H. Smith,Nan Wang,Darren M. Roberts,Garry G. Graham,Kenneth M. Williams,Richard O. Day
Drug Safety. 2013; 36(10): 953
[Pubmed]  [Google Scholar] [DOI]
7 A review of causes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children
C. Ferrandiz-Pulido,V. Garcia-Patos
Archives of Disease in Childhood. 2013; 98(12): 998
[Pubmed]  [Google Scholar] [DOI]
8 Cutaneous and systemic adverse reactions to antibiotics : Cutaneous and systemic adverse reactions
LUCIA DIAZ, ANA M. CIUREA
Dermatologic Therapy. 2012; 25(1): 12
[HTML Full text]  [Google Scholar] [DOI]
9 The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis
Y.-C. Huang,Y.-C. Li,T.-J. Chen
British Journal of Dermatology. 2012; 167(2): 424
[Pubmed]  [Google Scholar] [DOI]
10 Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options : SJS/TEN: review of treatment options
Scott Worswick, Jonathan Cotliar
Dermatologic Therapy. 2011; 24(2): 207
[HTML Full text]  [Google Scholar] [DOI]
11 Toxic epidermal necrolysis and Stevens-Johnson syndrome: A review* :
Roland Gerull, Mathias Nelle, Thomas Schaible
Critical Care Medicine. 2011; 39(6): 1521
[HTML Full text]  [Google Scholar] [DOI]
12 Indications and safety of intravenous and subcutaneous immunoglobulin therapy
Nima Rezaei, Hassan Abolhassani, Asghar Aghamohammadi, Hans D Ochs
Expert Review of Clinical Immunology. 2011; 7(3): 301
[HTML Full text]  [Google Scholar] [DOI]
13 Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children
Finkelstein, Y., Soon, G.S., Acuna, P., George, M., Pope, E., Ito, S., Shear, N.H., (...), Garcia-Bournissen, F.
Pediatrics. 2011; 128(4): 723-728
[Pubmed]  [Google Scholar]
14 In a patient with toxic epidermal necrolysis, does intravenous immunoglobulin improve survival compared with supportive care?
Wootton, C.I., Patel, A.N., Williams, H.C.
Archives of Dermatology. 2011; 147(12): 1437-1440
[Pubmed]  [Google Scholar]
15 Treatment of Toxic Epidermal Necrolysis (TEN) with low dose intravenous immunoglobulin in child
Habib, A., Pasha, W., Raza, N.
Journal of the College of Physicians and Surgeons Pakistan. 2010; 20(3): 205-207
[Pubmed]  [Google Scholar]
16 Stevens-Johnson syndrome and toxic epidermal necrolysis in Asian children
Koh, M.J.-A., Tay, Y.-K.
Journal of the American Academy of Dermatology. 2010; 62(1): 54-60
[Pubmed]  [Google Scholar]
17 Toxic epidermal necrolysis and Stevens-Johnson syndrome
Harr, T., French, L.E.
Orphanet Journal of Rare Diseases. 2010; 5(1): art 39
[Pubmed]  [Google Scholar]
18 Severe Cutaneous Adverse Reactions: Acute Generalized Exanthematous Pustulosis, Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome
Harr, T., French, L.E.
Medical Clinics of North America. 2010; 94(4): 727-742
[Pubmed]  [Google Scholar]
19 Intravenous immunoglobulin use in toxic epidermal necrolysis and Stevens-Johnson syndrome: A case report | [Toksik epidermal nekrolizis ve Steven-Johnson sendromunda intravenöz immünglobülin kullanimi]
Soyer, Ö.U., Durmaz, E., Akçören, Z., Demirgüneş, E., Şekerel, B.E.
Cocuk Sagligi ve Hastaliklari Dergisi. 2010; 53(2): 136-140
[Pubmed]  [Google Scholar]
20 Severe Cutaneous Adverse Reactions: Acute Generalized Exanthematous Pustulosis, Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome
Thomas Harr, Lars E. French
Medical Clinics of North America. 2010; 94(4): 727
[HTML Full text]  [Google Scholar] [DOI]
21 Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of the experience with paediatric patients in a University Hospital : Stevens-Johnson syndrome and toxic epidermal necrolysis
C Ferrándiz-Pulido, D García-Fernández, P Domínguez-Sampedro, V García-Patos
Journal of the European Academy of Dermatology and Venereology. 2010; : no
[HTML Full text]  [Google Scholar] [DOI]
22 Stevens-Johnson syndrome and toxic epidermal necrolysis in Asian children
Mark Jean-Aan Koh,Yong-Kwang Tay
Journal of the American Academy of Dermatology. 2010; 62(1): 54
[Pubmed]  [Google Scholar] [DOI]
23 An update on Stevens–Johnson syndrome and toxic epidermal necrolysis in children
Mark Jean-Aan Koh,Yong-Kwang Tay
Current Opinion in Pediatrics. 2009; 21(4): 505
[Pubmed]  [Google Scholar] [DOI]
24 How effective are intravenous immunoglobulins in pediatric dermatology?
Arti Nanda
Expert Review of Dermatology. 2009; 4(1): 37
[Pubmed]  [Google Scholar] [DOI]
25 Toxic Epidermal Necrolysis in Children: Medical, Surgical, and Ophthalmologic Considerations :
Sunali Goyal, Punkaj Gupta, Colleen M. Ryan, Melanie Kazlas, Natan Noviski, Robert L. Sheridan
Journal of Burn Care & Research. 2009; 30(3): 437-449
[Pubmed]  [Google Scholar] [DOI]
26 Immune mediation of hypersensitivity adverse drug reactions: Implications for therapy
Rieder, M.J.
Expert Opinion on Drug Safety. 2009; 8(3): 331-343
[Pubmed]  [Google Scholar]
27 How effective are intravenous immunoglobulins in pediatric dermatology?
Nanda, A.
Expert Review of Dermatology. 2009; 4(1): 37-45
[Pubmed]  [Google Scholar]
28 An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children
Koh, M.J.-A., Tay, Y.-K.
Current Opinion in Pediatrics. 2009; 21(4): 505-510
[Pubmed]  [Google Scholar]
29 Immune mediation of hypersensitivity adverse drug reactions: implications for therapy
Michael J Rieder
Expert Opinion on Drug Safety. 2009; 8(3): 331
[Pubmed]  [Google Scholar] [DOI]
30 Intravenous immunoglobulin in the treatment of lamotrigine- induced toxic epidermal necrolysis
Shirazi, Z.S., Inaloo, S.
Iranian Journal of Allergy, Asthma and Immunology. 2008; 7(4): 239-241
[Pubmed]  [Google Scholar]
31 Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome
Mittmann N, Chan B, Knowles S, Cosentino L, Shear N
American Journal of Clinical Dermatology. 2006; 7(6): 359-368
[Pubmed]  [Google Scholar]
32 Off-Label Uses of Biologic Agents in Dermatology: A 2006 Update
Mary Jo. J. Kerns,Julia E. Graves,David I. Smith,Michael P. Heffernan
Seminars in Cutaneous Medicine and Surgery. 2006; 25(4): 226
[Pubmed]  [Google Scholar] [DOI]
33 Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis
Barzin Khalili,Sami L. Bahna
Annals of Allergy, Asthma & Immunology. 2006; 97(3): 272
[Pubmed]  [Google Scholar] [DOI]
34 Off-Label Uses of Biologic Agents in Dermatology: A 2006 Update
Kerns MJoJ, Graves JE, Smith DI, Heffernan MP
Seminars in Cutaneous Medicine and Surgery. 2006; 25(4): 226-240
[Pubmed]  [Google Scholar]
35 Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis
Khalili B, Bahna SL
Annals of Allergy, Asthma and Immunology. 2006; 97(3): 272-281
[Pubmed]  [Google Scholar]

 

Online since 15th March '04
Published by Wolters Kluwer - Medknow